Welcome : Guest

Intellia Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Intellia Therapeutics, Inc., which is principally involved in Gene Editing Business. Illustrated with 36 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66146
Price: $1800
Company Type: Public
Pages: 39
Date: January 2017
Market Data Tables: 36

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biologics......4
Table 1: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others, DNA Microarrays......5
Table 2: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......5
DNA Sequencing Devices......6
Table 3: DNA Sequencing Devices Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Instruments & Consumables, Service, and Workflow......6
Table 4: DNA Sequencing Devices Market Worldwide (2016-2020) in US$ Million......7
Gene Therapy......8
Table 5: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......8
Table 6: Gene Therapy Clinical Trials Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Phase I, n=1183, Phase I/II, n=384, Phase II, n=330, Phase II/III, n=20 and Phase III, n=74......9
Genomic Technology......10
Table 7: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Sequencing, and Other Reagents......10
Table 8: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......11
Table 9: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger......12
Table 10: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......13
Table 11: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......14
Genomic Tools......15
Table 12: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in situ hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......15
Genomics 2.0......16
Table 13: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......16
Table 14: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......17
Table 15: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......18
Table 16: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......19
Table 17: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......20
Table 18: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......21
Table 19: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......22
Table 20: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......23
Table 21: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......24
Table 22: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......25
Table 23: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......26
Table 24: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......27
Table 25: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......28
Table 26: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......29
Table 27: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......30
Next-Generation Sequencing (NGS)......31
Table 28: Next-Generation Sequencing (NGS) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Library Preparation and Other Sample Preparations......31
Table 29: NGS Sequencing Market in North America (2014) - Percentage Share Breakdown by leading Players - Illumina/Solexa; Life Technologies, Roche/454, and Helicos......32
Table 30: Next Generation Sequencing Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Exome, Targeted Panels, Whole Genome, and Others......33
Next-Generation Sequencing (NGS) Applications......34
Table 31: Global NGS Applications (2015) - Percentage Breakdown of Usage Share by End-Uses - Human Genome Research; Clinical Service Providers; Microorganisms, Plant and Animal Genetic Analysis and Molecular Diagnostics......34
Genomics 2.0......35
Table 32: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......35
Genotyping......36
Table 33: Market Shares of Leading Genotyping Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Affymetrix, Inc., Agilent Technologies, Illumina, Inc., and Others......36
Next Generation DNA Sequencing Systems......37
Table 34: Market Shares of Leading Next Generation DNA Sequencing Systems Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for BGI, Illumina, Inc., Thermo Fisher Scientific, Inc., and Others......37
Next-Generation Sequencing (NGS) Instruments and Consumables......38
Table 35: Market Shares of Leading Next-Generation Sequencing (NGS) Instrument and Consumable Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Illumina, Inc., Pacific Biosciences of California, Inc. and Others......38
Table 36: Market Shares of Leading Next-Generation Sequencing (NGS) Instrument Manufacturers Worldwide (2015) - Percentage Breakdown by Value for F. Hoffmann-La Roche AG, Illumina, Inc., Pacific Biosciences of California, Inc. and Others......39